118
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line

, , &
Pages 371-375 | Received 28 Aug 2009, Accepted 17 Oct 2010, Published online: 11 Feb 2010

References

  • Rivlin, R.S. Is garlic alternative medicine? J. Nutr. 2006, 136, 713S–715S.
  • Faziloglu, Y., Stanley, R.J., Moss, R.H., Van Stoecker, W., McLean, R.P. Colour histogram analysis for melanoma discrimination in clinical images. Skin. Res. Technol. 2003, 9, 147–156.
  • Dancey, A.L., Mahon, B.S., Rayatt, S.S. A review of diagnostic imaging in melanoma. J. Plast. Reconstr. Aesthet. Surg. 2008, 61, 1275–1283.
  • Chan, F.M., O’Donnell, B.A., Whitehead, K., Ryman, W., Sullivan, T.J. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007, 114, 187–192.
  • Molife, R., Hancock, B.W. Adjuvant therapy of malignant melanoma. Crit. Rev. Oncol. Hematol. 2002, 44, 81–102.
  • Rigual, N.R., Popat, S.R., Jayaprakash, V., Jaggernauth, W., Wong, M. Cutaneous head and neck melanoma: the old and the new. Expert. Rev. Anticancer Ther. 2008, 8, 403–412.
  • Eberle, J., Fecker, L.F., Hossini, A.M., Kurbanov, B.M., Fechner, H. Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma. Exp. Dermatol. 2008, 17, 1–11.
  • Balch, C.M., Soong, S.J., Smith, T., Ross, M.I., Urist, M.M., Karakousis, C.P., Temple, W.J., Mihm, M.C., Barnhill, R.L., Jewell, W.R., Wanebo, H.J., Desmond, R. Investigators from the Intergroup Melanoma Surgical Trial. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann. Surg. Oncol. 2001, 8, 101–108.
  • Bajetta, E., Del Vecchio, M., Bernard-Marty, C., Vitali, M., Buzzoni, R., Rixe, O., Nova, P., Aglione, S., Taillibert, S., Khayat, D. Metastatic melanoma: chemotherapy. Semin. Oncol. 2002, 29, 427–445.
  • Kirkwood, J.M., Strawderman, M.H., Ernstoff, M.S., Smith, T.J., Borden, E.C., Blum, R.H. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J. Clin. Oncol. 1996, 14, 7–17.
  • Ji, J., Li, J., Holmes, L.M., Burgin, K.E., Yu, X., Wagner, T.E., Wei, Y. Glycoinositol phospholipid-anchored interleukin 2 but not secreted interleukin 2 inhibits melanoma tumor growth in mice. Mol. Cancer Ther. 2002, 1, 1019–1024.
  • Kirkwood, J.M., Tarhini, A.A., Panelli, M.C., Moschos, S.J., Zarour, H.M., Butterfield, L.H., Gogas, H.J. Next generation of immunotherapy for melanoma. J. Clin. Oncol. 2008, 26, 3445–3455.
  • Pedersen, J.E., Barron, G. Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice. Int. J. Radiat. Oncol. Biol. Phys. 1984, 10, 1479–1482.
  • Shields, C.L., Cater, J., Shields, J.A., Chao, A., Krema, H., Materin, M., Brady, L.W. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch. Ophthalmol. 2002, 120, 933–940.
  • Dauda, M.M., Shehu, S.M. Malignant melanoma: a review. Niger. Postgrad. Med. J. 2005, 12, 125–130.
  • Kaur, S., Michael, H., Arora, S., Härkönen, P.L., Kumar, S. The in vitro cytotoxic and apoptotic activity of Triphala–an Indian herbal drug. J. Ethnopharmacol. 2005, 97, 15–20.
  • Liu, C., Xi, T., Lin, Q., Xing, Y., Ye, L., Luo, X., Wang, F. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs. Int. Immunopharmacol. 2008, 8, 1835–1841.
  • Keiss, H.P., Dirsch, V.M., Hartung, T., Haffner, T., Trueman, L., Auger, J., Kahane, R., Vollmar, A.M. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappaB activity. J. Nutr. 2003, 133, 2171–2175.
  • Avicenna, A.A., 980–1937 A.P., Al-Qanun Filtibb. p. 348.
  • Ghazanfari, T., Hassan, Z.M., Ebtekar, M., Ahmadiani, A., Naderi, G., Azar, A. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice. Scand. J. Immunol. 2000, 52, 491–495.
  • Ghazanfari, T., Hasan, Z.M., Ebrahimi, M. Immunomodulatory activity of a protein isolated from garlic. Int. Immunopharm. 2002, 51, 1540–1549.
  • Ghazanfari, T., Hassan, Z.M., Khamesipour, A. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment. J. Ethnopharmacol. 2006, 103, 333–337.
  • Hassan, Z.M., Yaraee, R., Zare, N., Ghazanfari, T., Sarraf Nejad, A.H., Nazori, B. Immunomodulatory affect of R10 fraction of garlic extract on natural killer activity. Int. Immunopharmacol. 2003, 3, 1483–1489.
  • Tavakkol-Afshari, J., Brook, A., Mousavi, S.H. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem. Toxicol. 2008, 46, 3443–3447.
  • Badisa, R.B., Tzakou, O., Couladis, M., Pilarinou, E. Cytotoxic activities of some Greek Labiatae herbs. Phytother. Res. 2003, 17, 472–476.
  • Milner, J.A., McDonald, S.S., Anderson, D.E., Greenwald, P. Molecular targets for nutrients involved with cancer prevention. Nutr. Cancer 2001, 41, 1–16.
  • Patya, M., Zahalka, M.A., Vanichkin, A., Rabinkov, A., Miron, T., Mirelman, D., Wilchek, M., Lander, H.M., Novogrodsky, A. Allicin stimulates lymphocytes and elicits an antitumor effect: a possible role of p21ras. Int. Immunol. 2004, 16, 275–281.
  • Takeyama, H., Hoon, S.D., Saxton, R.E., Morton, DL., Irie, RF. Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine. Oncology. 1993, 50, 63–69.
  • Ledezma, E., Apitz-Castro, R., Cardier, J. Apoptotic and anti-adhesion effect of ajoene, a garlic derived compound, on the murine melanoma B16F10 cells: possible role of caspase-3 and the alpha(4)beta(1) integrin. Cancer Lett. 2004, 206, 35–41.
  • Chowdhury, R., Dutta, A., Chaudhuri, S.R., Sharma, N., Giri, A.K., Chaudhuri, K. In vitro and in vivo reduction of sodium arsenite induced toxicity by aqueous garlic extract. Food Chem. Toxicol. 2008, 46, 740–751.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.